We compared polyclonal Tregs, which are a cellular medicinal product used in the treatment of type 1 diabetes, with Tregs specific and unspecific against whole insulin (index INS) or insulin β chain peptide 9-23 (index B:9-23). The gene discussed is INS; the disease is type 1 diabetes mellitus.